Translate this page into:
PEDIATRIC SECTION: Editorial
doi:
10.4103/2278-330X.119889
Chronic myeloid leukemia in India: The poster child of translational medicine needs help!
1
Department of Haematology, Kingston NHS Trust and Royal Marsden Hospital, St. George’s Medical School, London, UK
*Corresponding author: Dr. Vishal Jayakar. vishal.jayakar@kingstonhospital.nhs.uk
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Raut SL, Bohara VV, Ray SS, Chakrabarti P, Utpal C. Chronic myeloid leukemia in children and adolescents: A single center experience from eastern India. South Asian J Cancer 2013;4:260-4.
- Björkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjöberg J, et al. Success story of targeted therapy in chronic myeloid leukemia: A population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol 2011;29:2514-20.
- Andolina JR, Neudorf SM, Corey SJ. How I treat childhood CML. Blood 2012;119:1821-30.
- Champagne MA, Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, et al. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: Results from a children′s oncology group phase 1 study. Blood 2004;104:2655-60.
- Millot F, Baruchel A, Guilhot J, Petit A, Leblanc T, Bertrand Y, et al. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: Results of the French national phase IV trial. J Clin Oncol 2011;29:2827-32.